# Ginkgo Bioworks Holdings, Inc.: Form 8-K, filed May 13, 2024

- Company: [Ginkgo Bioworks Holdings, Inc.](/companies/dna.md) (CIK 1830214)
- Form: 8-K
- Filed: 2024-05-13
- Accepted by EDGAR: May 13, 2024, 16:14 ET
- Period: 2024-05-07
- Accession: 0001628280-24-022896
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1830214/000162828024022896/dna-20240507.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1830214/000162828024022896/

## Items reported

- Item 3.01: Delisting notice
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1830214/000162828024022896/dna-20240507.htm

Filed May 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-022896. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.